Predictors of poor precautionary practices towards COVID-19 among cancer patients
…, Z Benbrahim, MO Alorabi, AM Abusanad… - Future …, 2021 - Future Medicine
Objective: Our study goal was to evaluate the behavioral response and practices of cancer
patients to the coronavirus disease 2019 (COVID-19) pandemic in the Middle East and north …
patients to the coronavirus disease 2019 (COVID-19) pandemic in the Middle East and north …
[HTML][HTML] Utilizing peripheral blood inflammatory biomarker (PBIB) to predict response to systemic therapy in patients with breast cancer
A Abusanad - Journal of Family Medicine and Primary Care, 2023 - journals.lww.com
Background: Inflammation is a recognized factor in cancer progression and resistance to
treatments. Several studies correlated inflammation-related peripheral blood inflammatory …
treatments. Several studies correlated inflammation-related peripheral blood inflammatory …
Implementation of breast cancer continuum of care in low-and middle-income countries during the COVID-19 pandemic
…, A Abusanad, MM Hussein, M Alorabi… - Future …, 2020 - Future Medicine
Breast cancer is the most common malignancy among women worldwide. The current COVID-19
pandemic represents an unprecedented challenge leading to care disruption, which is …
pandemic represents an unprecedented challenge leading to care disruption, which is …
[HTML][HTML] Association between MDR1 polymorphisms and XELIRI and XELOX chemoresistance in Saudi patients with colorectal cancer
…, HM Tashkandi, AM Abusanad… - Oncology …, 2020 - spandidos-publications.com
Multidrug resistance member 1 (MDR1) is located on chromosome 7 and encodes P‑glycoprotein,
which is universally accepted as a drug resistance biomarker. MDR1 polymorphisms …
which is universally accepted as a drug resistance biomarker. MDR1 polymorphisms …
[HTML][HTML] Novel association between heterozygous genotype of single nucleotide polymorphism C218T in drug transporter ABCC1 gene and increased risk of colon …
…, A Yezerski, HA Al Doghaither, AM Abusanad… - Saudi Medical …, 2019 - ncbi.nlm.nih.gov
Objectives: To determine the role of G128C and C218T variants in ABCC1 gene with the
risk of developing colon cancer in Jeddah, Kingdom of Saudi Arabia. Methods: This case-…
risk of developing colon cancer in Jeddah, Kingdom of Saudi Arabia. Methods: This case-…
[HTML][HTML] Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples
…, O Bajouh, S Al-Khayyat, R Alam, A Abusanad… - Journal of translational …, 2016 - Springer
Background Colorectal cancer (CRC) is a heterogeneous disease with different molecular
characteristics associated with many variables such as the sites from which the tumors …
characteristics associated with many variables such as the sites from which the tumors …
The perception of cervical cancer screening and prevention among Saudi women.
AM Abusanad, L Alharbi, S Alsalamah, M Almasary… - 2023 - ascopubs.org
e17519 Background: Cervical cancer (CC) is the fourth cause of malignancy-related deaths
among women globally. In Saudi Arabia, it is the 8th most prevalent cancer and the 7 th …
among women globally. In Saudi Arabia, it is the 8th most prevalent cancer and the 7 th …
Survival in patients with brain metastasis secondary to breast cancer from Saudi Arabia.
AM Abusanad, O Iskanderani, MR Al-hajeili, R Ujaimi… - 2023 - ascopubs.org
e14018 Background: Breast cancer (BC) is the most common malignancy in women from
Saudi Arabia. Nearly one-third of the patients present with metastatic disease. Data on the …
Saudi Arabia. Nearly one-third of the patients present with metastatic disease. Data on the …
[PDF][PDF] General oncology care in the kingdom of Saudi Arabia
A Abusanad, M Alghamdi, M Bakkar… - Cancer in the arab …, 2022 - library.oapen.org
… Abusanad specializes in breast and GI cancers and completed a Clinician-investigator
fellowship (CIP) at McGill University, along with an MSc in experimental medicine and molecular …
fellowship (CIP) at McGill University, along with an MSc in experimental medicine and molecular …
[HTML][HTML] Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
A Abu-Sanad, Y Wang, F Hasheminasab… - Frontiers in …, 2015 - frontiersin.org
Enhanced DNA damage repair is one mechanism involved in colon cancer drug resistance.
Thus, targeting molecular components of repair pathways with specific small molecule …
Thus, targeting molecular components of repair pathways with specific small molecule …